These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 26830677

  • 1. Targeting autophagy to sensitive glioma to temozolomide treatment.
    Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z.
    J Exp Clin Cancer Res; 2016 Feb 02; 35():23. PubMed ID: 26830677
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T, Li A, Xu Y, Xin Y.
    Oncol Rep; 2019 Mar 02; 41(3):1883-1892. PubMed ID: 30664175
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan 02; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 10. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
    Ryabaya OO, Inshakov AN, Egorova AV, Emelyanova MA, Nasedkina TV, Zasedatelev AS, Khochenkov DA, Stepanova EV.
    Anticancer Drugs; 2017 Mar 02; 28(3):307-315. PubMed ID: 27941537
    [Abstract] [Full Text] [Related]

  • 11. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
    Noack J, Choi J, Richter K, Kopp-Schneider A, Régnier-Vigouroux A.
    Cell Death Dis; 2014 Sep 25; 5(9):e1425. PubMed ID: 25255218
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.
    Cell Cycle; 2015 Sep 25; 14(21):3418-29. PubMed ID: 26566863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC.
    Expert Rev Neurother; 2010 Oct 25; 10(10):1537-44. PubMed ID: 20925470
    [Abstract] [Full Text] [Related]

  • 16. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 17. Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells.
    Zhu Z, Zhang P, Li N, Kiang KMY, Cheng SY, Wong VK, Leung GK.
    Biomed Res Int; 2019 Oct 10; 2019():2710693. PubMed ID: 31662972
    [Abstract] [Full Text] [Related]

  • 18. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells.
    Hori YS, Hosoda R, Akiyama Y, Sebori R, Wanibuchi M, Mikami T, Sugino T, Suzuki K, Maruyama M, Tsukamoto M, Mikuni N, Horio Y, Kuno A.
    J Neurooncol; 2015 Mar 10; 122(1):11-20. PubMed ID: 25528635
    [Abstract] [Full Text] [Related]

  • 19. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.
    Mol Pharm; 2018 Nov 05; 15(11):4912-4925. PubMed ID: 30336060
    [Abstract] [Full Text] [Related]

  • 20. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    Cheng Y, Sk UH, Zhang Y, Ren X, Zhang L, Huber-Keener KJ, Sun YW, Liao J, Amin S, Sharma AK, Yang JM.
    PLoS One; 2012 Nov 05; 7(4):e35104. PubMed ID: 22496897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.